말초 정맥주사를 통해 비항암제 발포성 약물을 투약한 성인 환자의 일혈 발생과 위험요인 = Factors Related to Extravasation of Non-chemotherapy Vesicant Drugs in Peripheral Vein Catheters

다국어 초록 (Multilingual Abstract)

Purpose : This study aimed to investigate the incidence of intravenous extravasation and the risk factors associated with the use of peripheral intravenous catheters in adults. Method : This prospective observational study included 203 adult patients admitted to the general ward who received non-chemotherapy vesicant drug infusion treatments. Data were analyzed using frequencies, percentage, means, standard deviations, and odds ratios (ORs) from multiple logistic regressions. Results : The incidence of extravasation was 43.3%. Risk factors for intravenous extravasation included continuous injections (OR=5.35, 95% CI [1.38, 20.83]), and parenteral nutrition (OR=3.53, 95% CI [1.43, 8.73]). Conclusion : The present findings revealed that gastrointernal medicine problems, continuous injection, and parenteral nutrition were related to intravenous extravasation. Further research is necessary to reduce the incidence of extravasation related to peripheral intravenous catheterization in adults, and to prevent secondary complications. Finally, patients should be provided appropriate and continuous care based on the type of intravenous infusion.

참고문헌 (Reference)

1 구미옥, "정맥주입요법 간호실무지침 수용개작" 병원간호사회 19 (19): 128-142, 2013

2 김경아, "간기능검사의 이해와 적용" 대한내과학회 76 (76): 163-168, 2009

3 Sauerland, C., "Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk" 33 (33): 1134-1141, 2006

4 Schulmeister, L., "Vesicant chemotherapy extravasation management" 20 (20): S6-S12, 2011

5 Harrold, K., "The management of cytotoxic chemotherapy extravasation: a systematic review of the literature to evaluate the evidence underpinning contemporary practice" 24 (24): 771-800, 2015

6 Dougherty, L., "The Royal Marsden manual of clinical nursing procedures" John Wiley & Sons Inc 2015

7 Ahmed, A., "Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management" Saunders 1575-1587, 2006

8 Hadaway, L., "Short peripheral intravenous catheters and infections" 35 (35): 230-240, 2012

9 Fernandez-Garcia, C., "Related factors with extravasation of non-cytostatic agents in peripheral vein catheters" 27 (27): 71-78, 2017

10 Perez Fidalgo, J. A., "Management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines" 16 (16): 528-534, 2012

11 Infusion Nurses Society, "Infusion nursing standards of practice" 29 : S1-S138, 2016

12 Doellman, D., "Infiltration and extravasation: update on prevention and management" 32 (32): 203-211, 2009

13 Hadaway, L., "Infiltration and extravasation-Preventing a complication of IV catheterization" 107 (107): 64-72, 2007

14 Woody, G., "Increasing nurse competence in peripheral intravenous therapy" 36 (36): 413-419, 2013

15 Taylor, J. T., "Implementing an evidence-based practice project in the prevention of peripheral intravenous site infiltrations in children" 38 (38): 430-435, 2015

16 Dougherty, L., "IV therapy: recognizing the differences between infiltration and extravasation" 17 (17): 896-901, 2008

17 O'Grady, N. P., "Guidelines for the prevention of intravascular catheter-related infections" 39 (39): 1-34, 2011

18 Dougherty, L., "Extravasation: prevention, recognition and management" 24 (24): 48-55, 2010

19 Martin, S. M., "Extravasation management of nonchemotherapeutic medications" 36 (36): 392-396, 2013

20 Goutos, I., "Extravasation injuries: a review" 39 (39): 808-818, 2014

21 Kassne, E., "Evaluation and treatment of chemotherapy extravasation injuries" 17 (17): 135-148, 2000

22 Wengstrom Y., "European oncology nursing society extravasation guidelines" 12 (12): 357-361, 2008